Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Lenox Pasifik Investama Tbk. (LPPS)

Indofarma Tbk.Trading
Lenox Pasifik Investama Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofarma Tbk. dan Lenox Pasifik Investama Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Lenox Pasifik Investama Tbk. diperdagangkan di Rp82 (kapitalisasi pasar 214,82 M, volume 24 jam 1,6 jt). Perbedaan utamanya: Indofarma Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

INAFLPPS
Kapitalisasi Pasar
390,51 M214,82 M
Volume
1,6 jt
Lot
16,02 rb
Perputaran
129,47 jt
Harga Rata-rata
80,8
Nilai Transaksi
129,47 jt
Harga Ekuilibrium Indikatif
82
Volume Ekuilibrium Indikatif
286

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INAF
Lihat detail
LPPS
Lihat detail

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF

Tentang Lenox Pasifik Investama Tbk.

PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.

Selengkapnya di halaman LPPS